ELIZABETH CAMPBELL: Open Payments
NPI 1780109314 · NICHOLASVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 24 payments from 20 companies in 2025. Trend: 2023 $342 · 2024 $728 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Amgen Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| CSL Behring | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: JARDIANCE, CAPLYTA, OTEZLA, QULIPTA, Dexcom G6 Transmitter, FANAPT, Auvelity, Andembry.
Industry payments across KY — which companies pay providers there.
